Quality of Life in Children Cured of Retinoblastoma

Status Recruiting

Clinical Trial Summary

The aim of the study is to assess the quality of life of children who have been cured of retinoblastoma - a malignant eye tumor. The study is questionnaire-based, and uses standardized quality of life assessment tools.

Clinical Trial Description

Retinoblastoma is the most common eye tumor of children. It can present in one eye (unilateral) or in both eyes (bilateral). The bilateral form is always hereditary.

Retinoblastoma is a highly curable tumor. Using a combination of surgery, chemotherapy, radiation and local treatment modalities to the eye, over 98% of patients are cured. This means that most children diagnosed with retinoblastoma will become long-term survivors.

The use of surgery (taking out one eye), chemotherapy, and radiation may be associated with long term side-effects, some of which may have significant impact on the quality of life of the child. In addition, in case where the disease is hereditary, additional psychological issues arise.

The aim of our study is to assess, in a comprehensive and standardized fashion, the long term quality of life in children who were treated for retinoblastoma, and who are currently alive and well.

The assessment will include the use of questionnaires that assess quality of life, as well as participation in age-appropriate activities.

Each child, and his/her parent, will be interviewed and the questionnaires completed. The process will take about one hour for each child. No risk or discomfort to the child is involved. ;

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

Retinoblastoma

Clinical Trial Details

NCT number	NCT00278031
Study type	Observational
Source	Hadassah Medical Organization
Contact	Michael Weintraub, MD
Phone	972-2-6777408
Email	michaelw@hadassah.org.il
Status	Recruiting
Phase	N/A
Start date	March 2006
Completion date	December 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04564521` - Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma.	N/A
Recruiting	`NCT02933333` - G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor	Phase 4
Withdrawn	`NCT01151748` - Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma	Phase 2
Completed	`NCT01048892` - Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features	Phase 1
Active, not recruiting	`NCT00360750` - Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye	N/A
Completed	`NCT00003173` - High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors	Phase 2
Enrolling by invitation	`NCT06227962` - Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors
Completed	`NCT01661400` - Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors	Phase 1
Terminated	`NCT02617862` - PCI Imaging System in Pediatric Ophthalmology	N/A
Recruiting	`NCT02329002` - SPT Screening in Irradiated Hereditary Retinoblastoma Survivors	N/A
Terminated	`NCT01466855` - A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma	Early Phase 1
Completed	`NCT01505569` - Auto Transplant for High Risk or Relapsed Solid or CNS Tumors	N/A
Completed	`NCT00002515` - Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer	Phase 2
Enrolling by invitation	`NCT03655223` - Early Check: Expanded Screening in Newborns
Completed	`NCT06367569` - Evaluation of MRI of the Pineal Gland in Retinoblastoma
Completed	`NCT02193724` - Feasibility of Generating Pluripotent Stem Cells From Patients With Familial Retinoblastoma
Completed	`NCT01884194` - Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging	N/A
Terminated	`NCT01393769` - Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage	Phase 2
Completed	`NCT00006246` - Busulfan in Treating Children and Adolescents With Refractory CNS Cancer	Phase 1
Terminated	`NCT00003926` - Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors	Phase 1